Peter Guenter
Director/Board Member bij GALAPAGOS NV
Vermogen: 63 637 $ op 31-03-2024
Profiel
Mr. Peter Guenter is a Member-Management Board & CEO-Healthcare at Merck KGaA and an Independent Non-Executive Director at Galapagos NV.
He is on the Board of Directors at Galapagos NV and European Federation of Pharmaceutical Industries & Assns.
Mr. Guenter was previously employed as a Chief Executive Officer & Director by Almirall SA, an Executive Vice President by Smithkline Beecham, an EVP, General Manager-Diabetes & Cardiovascular by Sanofi, and a Chairman-Supervisory Board by Sanofi-Aventis Deutschland GmbH.
He received his graduate degree from Ghent University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GALAPAGOS NV
0.00% | 15-03-2024 | 1 992 ( 0.00% ) | 63 637 $ | 31-03-2024 |
Actieve functies van Peter Guenter
| Bedrijven | Functie | Begin |
|---|---|---|
| GALAPAGOS NV | Director/Board Member | 30-04-2019 |
| MERCK KGAA | Corporate Officer/Principal | 01-01-2021 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Director/Board Member | - |
Eerdere bekende functies van Peter Guenter
| Bedrijven | Functie | Einde |
|---|---|---|
| ALMIRALL, S.A. | Chief Executive Officer | 31-12-2020 |
| SANOFI | Corporate Officer/Principal | 01-08-2017 |
| Smithkline Beecham | Corporate Officer/Principal | - |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Chairman | - |
Opleiding van Peter Guenter
| Ghent University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MERCK KGAA | Health Technology |
| SANOFI | Health Technology |
| GALAPAGOS NV | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
| Smithkline Beecham |
